Trials / Completed
CompletedNCT05856058
To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability
To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability (Single-center, Random, Open, Crossed)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To assess the relative bioavailability of SHR0302 oral solution and tablet in healthy subjects. To assess the safety and tolerability of a single dose of SHR0302 oral solution and tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0302 | SHR0302 oral solution 1 time, SHR0302 tablets 1 time |
Timeline
- Start date
- 2023-05-29
- Primary completion
- 2023-07-03
- Completion
- 2023-10-09
- First posted
- 2023-05-12
- Last updated
- 2023-12-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05856058. Inclusion in this directory is not an endorsement.